Mark Peakman

9PUBLICATIONS
78CO-AUTHORS
Solid tumoursImmunogenetics (incl. genetic immunology)AutoimmunityNutrigenomics and personalised nutritionMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 27, 2026
A Phase 2 Trial of Frexalimab, a CD40L Antagonist, in Adolescents and Adults With Recent-Onset Type 1 Diabetes (FABULINUS): Rationale and Study Design.

|Feb 28, 2025
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes affirms markers of disease.

Robert Moulder, M Karoliina Hirvonen, Tommi Välikangas

|Oct 30, 2024
Physiological and pathogenic T cell autoreactivity converge in type 1 diabetes.

Anne Eugster, Anna Lorenc, Martin Kotrulev

|Jun 04, 2024
Gut microbiome shifts in people with type 1 diabetes are associated with glycaemic control: an INNODIA study.

Tommi Vatanen, Carine de Beaufort, M Loredana Marcovecchio

|Aug 03, 2023
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectory.

Robert Moulder, Tommi Välikangas, M Karoliina Hirvonen

|Jul 22, 2022
Detection of enterovirus RNA in peripheral blood mononuclear cells correlates with the presence of the predisposing allele of the type 1 diabetes risk gene IFIH1 and with disease stage.

Amir-Babak Sioofy-Khojine, Sarah J Richardson, Jonathan M Locke

Pageof 2

Frequent Collaborators

4 joint publications

Mikael Knip

3 joint publications

Chantal Mathieu

3 joint publications

Soren Brunak

3 joint publications

Lut Overbergh